Incoming news on Clinical Trials in a hot M&A sector. Still Relatively cheap at $15 m MC. Solid Science and management at the wheel.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
